Contribution of CYP2C19 and CYP3A4 to the formation of the active nortilidine from the prodrug tilidine

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Grün, Barbara (VerfasserIn) , Merkel, Ulrike Hannah (VerfasserIn) , Riedel, Klaus-Dieter (VerfasserIn) , Weiß, Johanna (VerfasserIn) , Mikus, Gerd (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2 March 2012
In: British journal of clinical pharmacology
Year: 2012, Jahrgang: 74, Heft: 5, Pages: 854-863
ISSN:1365-2125
DOI:10.1111/j.1365-2125.2012.04261.x
Online-Zugang:Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1111/j.1365-2125.2012.04261.x
Resolving-System, kostenfrei, Volltext: https://doi.org/10.1111/j.1365-2125.2012.04261.x
Volltext
Verfasserangaben:Barbara Grün, Ulrike Merkel, Klaus‐Dieter Riedel, Johanna Weiss & Gerd Mikus

MARC

LEADER 00000caa a2200000 c 4500
001 1576420353
003 DE-627
005 20220814164444.0
007 cr uuu---uuuuu
008 180615s2012 xx |||||o 00| ||eng c
024 7 |a 10.1111/j.1365-2125.2012.04261.x  |2 doi 
035 |a (DE-627)1576420353 
035 |a (DE-576)506420353 
035 |a (DE-599)BSZ506420353 
035 |a (OCoLC)1341011815 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Grün, Barbara  |e VerfasserIn  |0 (DE-588)1161226311  |0 (DE-627)1024632121  |0 (DE-576)506420922  |4 aut 
245 1 0 |a Contribution of CYP2C19 and CYP3A4 to the formation of the active nortilidine from the prodrug tilidine  |c Barbara Grün, Ulrike Merkel, Klaus‐Dieter Riedel, Johanna Weiss & Gerd Mikus 
264 1 |c 2 March 2012 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 15.06.2018 
700 1 |a Merkel, Ulrike Hannah  |d 1984-  |e VerfasserIn  |0 (DE-588)1025370821  |0 (DE-627)722174934  |0 (DE-576)370274970  |4 aut 
700 1 |a Riedel, Klaus-Dieter  |e VerfasserIn  |0 (DE-588)1034229605  |0 (DE-627)745128432  |0 (DE-576)381859460  |4 aut 
700 1 |a Weiß, Johanna  |e VerfasserIn  |0 (DE-588)1050230906  |0 (DE-627)783666322  |0 (DE-576)404441114  |4 aut 
700 1 |a Mikus, Gerd  |e VerfasserIn  |0 (DE-588)110903137  |0 (DE-627)691097941  |0 (DE-576)336988710  |4 aut 
773 0 8 |i Enthalten in  |t British journal of clinical pharmacology  |d Oxford : Wiley-Blackwell, 1974  |g 74(2012), 5, Seite 854-863  |h Online-Ressource  |w (DE-627)306585995  |w (DE-600)1498142-7  |w (DE-576)091140056  |x 1365-2125  |7 nnas  |a Contribution of CYP2C19 and CYP3A4 to the formation of the active nortilidine from the prodrug tilidine 
773 1 8 |g volume:74  |g year:2012  |g number:5  |g pages:854-863  |g extent:10  |a Contribution of CYP2C19 and CYP3A4 to the formation of the active nortilidine from the prodrug tilidine 
856 4 0 |u http://dx.doi.org/10.1111/j.1365-2125.2012.04261.x  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://doi.org/10.1111/j.1365-2125.2012.04261.x  |x Resolving-System  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20180615 
993 |a Article 
994 |a 2012 
998 |g 110903137  |a Mikus, Gerd  |m 110903137:Mikus, Gerd  |d 910000  |d 910100  |e 910000PM110903137  |e 910100PM110903137  |k 0/910000/  |k 1/910000/910100/  |p 5  |y j 
998 |g 1050230906  |a Weiß, Johanna  |m 1050230906:Weiß, Johanna  |d 910000  |d 910100  |e 910000PW1050230906  |e 910100PW1050230906  |k 0/910000/  |k 1/910000/910100/  |p 4 
998 |g 1034229605  |a Riedel, Klaus-Dieter  |m 1034229605:Riedel, Klaus-Dieter  |d 910000  |d 910100  |e 910000PR1034229605  |e 910100PR1034229605  |k 0/910000/  |k 1/910000/910100/  |p 3 
998 |g 1025370821  |a Merkel, Ulrike Hannah  |m 1025370821:Merkel, Ulrike Hannah  |d 910000  |d 910100  |e 910000PM1025370821  |e 910100PM1025370821  |k 0/910000/  |k 1/910000/910100/  |p 2 
998 |g 1161226311  |a Grün, Barbara  |m 1161226311:Grün, Barbara  |d 910000  |d 950000  |d 950900  |e 910000PG1161226311  |e 950000PG1161226311  |e 950900PG1161226311  |k 0/910000/  |k 1/910000/950000/  |k 2/910000/950000/950900/  |p 1  |x j 
999 |a KXP-PPN1576420353  |e 3012766170 
BIB |a Y 
SER |a journal 
JSO |a {"recId":"1576420353","name":{"displayForm":["Barbara Grün, Ulrike Merkel, Klaus‐Dieter Riedel, Johanna Weiss & Gerd Mikus"]},"origin":[{"dateIssuedKey":"2012","dateIssuedDisp":"2 March 2012"}],"id":{"doi":["10.1111/j.1365-2125.2012.04261.x"],"eki":["1576420353"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"physDesc":[{"extent":"10 S."}],"language":["eng"],"title":[{"title_sort":"Contribution of CYP2C19 and CYP3A4 to the formation of the active nortilidine from the prodrug tilidine","title":"Contribution of CYP2C19 and CYP3A4 to the formation of the active nortilidine from the prodrug tilidine"}],"person":[{"given":"Barbara","role":"aut","family":"Grün","display":"Grün, Barbara"},{"display":"Merkel, Ulrike Hannah","role":"aut","given":"Ulrike Hannah","family":"Merkel"},{"display":"Riedel, Klaus-Dieter","family":"Riedel","given":"Klaus-Dieter","role":"aut"},{"role":"aut","given":"Johanna","family":"Weiß","display":"Weiß, Johanna"},{"family":"Mikus","given":"Gerd","role":"aut","display":"Mikus, Gerd"}],"relHost":[{"title":[{"subtitle":"BJCP","title":"British journal of clinical pharmacology","title_sort":"British journal of clinical pharmacology"}],"physDesc":[{"extent":"Online-Ressource"}],"pubHistory":["1.1974 -"],"language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"},"titleAlt":[{"title":"BJCP"}],"note":["Gesehen am 20.03.2014"],"part":{"text":"74(2012), 5, Seite 854-863","extent":"10","volume":"74","pages":"854-863","issue":"5","year":"2012"},"id":{"doi":["10.1111/(ISSN)1365-2125"],"eki":["306585995"],"zdb":["1498142-7"],"issn":["1365-2125"]},"origin":[{"dateIssuedDisp":"1974-","dateIssuedKey":"1974","publisher":"Wiley-Blackwell ; Blackwell Science ; Blackwell","publisherPlace":"Oxford ; Oxford ; Oxford [u.a.]"}],"disp":"Contribution of CYP2C19 and CYP3A4 to the formation of the active nortilidine from the prodrug tilidineBritish journal of clinical pharmacology","recId":"306585995"}],"note":["Gesehen am 15.06.2018"]} 
SRT |a GRUENBARBACONTRIBUTI2201